Physicians seeking greater sensitivity in detecting and managing lung nodules now have a relatively low-dose alternative to chest x-rays. GE’s VolumeRAD Tomosynthesis has been shown to be 7.5 times more effective in identifying lung nodules 4-6 mm in diameter, while exposing patients to only 1.6 times more radiation than a 2 view (PA and LAT) chest x-ray exam, according to an internal GE study. VolumeRAD is the first thoracic radiographic tomosynthesis product with a specific indication.
“Rather than simply getting a CT, we can do a VolumeRAD to verify whether it’s a nodule or not,” said Dr. Gautham Reddy, professor of Radiology and vice chair for Education and director of Thoracic Imaging in the Department of Radiology at the University of Washington. “[For] something that has low likelihood of being a nodule, VolumeRAD will probably exclude the possibility of a nodule and there won’t be as much radiation.”
For more information, visit GE Healthcare.
